Evidence map›Paper›PMID 30770445›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.

Joy Mitra, Erika N Guerrero, Pavana M Hegde, Nicole F Liachko, Haibo Wang, Velmarini Vasquez, Junling Gao, Arvind Pandey, J Paul Taylor, Brian C Kraemer and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 3 pooled it
25.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 3 syntheses or guidelines pooled it, 312 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Joy MitraDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
Erika N GuerreroDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
Pavana M HegdeDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
Nicole F LiachkoGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108.
Haibo WangDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
Velmarini VasquezDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
Junling GaoDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555.
Arvind PandeyDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
J Paul TaylorDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Brian C KraemerGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108.
Ping WuDepartment of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555.
Istvan BoldoghDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Ralph M GarrutoDepartment of Anthropology, Binghamton University, State University of New York, Binghamton, NY 13902; rgarruto@binghamton.edu mlhegde@houstonmethodist.org.
Sankar MitraDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030.
K S RaoCenter for Neuroscience, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología, City of Knowledge, Panama, Republic of Panama.
Muralidhar L HegdeDepartment of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030; rgarruto@binghamton.edu mlhegde@houstonmethodist.org.
Houston Methodist · USThe University of Texas Medical Branch at Galveston · USInstituto de Investigaciones Científicas y Servicios de Alta Tecnología · PAUniversity of Puget Sound · USBinghamton University · USCornell University · USHoward Hughes Medical Institute · US

Funding

Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BOLDOGH, ISTVAN STEVEN · 2005 to 2022
$23.9M
Etiological Linkage of DNA Damage/Repair Deficiency in Neurodegenerative DiseasesR01NS088645 · NINDS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI HEGDE, MURALIDHAR L · 2015 to 2019
$1.8M
Investigating calcineurin regulation of pathological TDP-43 phosphorylation in ALSI01BX004044 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI LIACHKO, NICOLE FARON · 2019 to 2022
–
BLRD VA I01 BX003755BLRD VA I01 BX004044NIAID NIH HHS P01 AI062885NINDS NIH HHS R01 NS088645
6 · The paper itself

Abstract

Genome damage and their defective repair have been etiologically linked to degenerating neurons in many subtypes of amyotrophic lateral sclerosis (ALS) patients; however, the specific mechanisms remain enigmatic. The majority of sporadic ALS patients feature abnormalities in the transactivation response DNA-binding protein of 43 kDa (TDP-43), whose nucleo-cytoplasmic mislocalization is characteristically observed in spinal motor neurons. While emerging evidence suggests involvement of other RNA/DNA binding proteins, like FUS in DNA damage response (DDR), the role of TDP-43 in DDR has not been investigated. Here, we report that TDP-43 is a critical component of the nonhomologous end joining (NHEJ)-mediated DNA double-strand break (DSB) repair pathway. TDP-43 is rapidly recruited at DSB sites to stably interact with DDR and NHEJ factors, specifically acting as a scaffold for the recruitment of break-sealing XRCC4-DNA ligase 4 complex at DSB sites in induced pluripotent stem cell-derived motor neurons. shRNA or CRISPR/Cas9-mediated conditional depletion of TDP-43 markedly increases accumulation of genomic DSBs by impairing NHEJ repair, and thereby, sensitizing neurons to DSB stress. Finally, TDP-43 pathology strongly correlates with DSB repair defects, and damage accumulation in the neuronal genomes of sporadic ALS patients and in

Indexed as

DNA Breaks, Double-StrandedDNA RepairAmyotrophic Lateral SclerosisAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsDNA-Binding ProteinsDNA End-Joining RepairHumansMotor NeuronsProtein BindingRNA-Binding ProteinsCaenorhabditis elegans ProteinsDNA-Binding ProteinsRNA-Binding ProteinsTARDBP protein, humanTDP-1 protein, C elegansXRCC4 protein, humanamyotrophic lateral sclerosisDNA damage responseDNA double-strand break repairneurodegenerationTDP-43

Identifiers

PMID30770445
PMCPMC6410842
OpenAlexW2807481171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.